WO2024079524 - SCD2+ STROMAL CELLS FOR TREATING DIABETIC KIDNEY DISEASE
National phase entry:
Publication Number
WO/2024/079524
Publication Date
18.04.2024
International Application No.
PCT/IB2023/000587
International Filing Date
12.10.2023
Title **
[English]
SCD2+ STROMAL CELLS FOR TREATING DIABETIC KIDNEY DISEASE
[French]
CELLULES STROMALES SCD2+ POUR LE TRAITEMENT DE LA NÉPHROPATHIE DIABÉTIQUE
Applicants **
ORBSEN THERAPEUTICS LIMITED
Inventors
COUTURE, Larry, A.
ELLIMAN, Stephen, J.
Priority Data
63/379,352
13.10.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2441 | |
| EPO | Filing, Examination, Granting | 10922 | |
| Japan | Filing, Examination, Granting | 2246 | |
| South Korea | Filing, Examination, Granting | 2254 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,603
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Provided herein are compositions and methods for treating kidney disease, for example diabetic kidney disease, using compositions comprising SDC2+ stromal stem cells.[French]
L'invention concerne des compositions et des méthodes de traitement d'une néphropathie, par exemple une néphropathie diabétique, à l'aide de compositions comprenant des cellules souches stromales SDC2+.